Methods for monitoring heterologous sex chromosomes
CA 2264450 A1 · Owner: Nagy, Andras · Inventors: Hadjantonakis, Anna-Katerina; Nagy, Andras
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Pluripotent cells comprising a nucleic acid sequence encoding a fluorescent protein marker, selectively integrated into a heterologous sex chromosome in the cell; embryos and, transgenic animals produced using the pluripotent cells; and the uses of such , cells, embryos, and animals are described.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 5, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 5, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 5, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.